Simultaneous Optical Imaging of Action Potentials and Calcium Transients in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
- PMID: 38980221
- DOI: 10.1002/cpz1.1101
Simultaneous Optical Imaging of Action Potentials and Calcium Transients in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Abstract
Cardiovascular diseases have emerged as one of the leading causes of human mortality, but the discovery of new drugs has been hindered by the absence of suitable in vitro platforms. In recent decades, continuously refined protocols for differentiating human induced pluripotent stem cells (hiPSCs) into hiPSC-derived cardiomyocytes (hiPSC-CMs) have significantly advanced disease modeling and drug screening; however, this has led to an increasing need to monitor the function of hiPSC-CMs. The precise regulation of action potentials (APs) and intracellular calcium (Ca2+) transients is critical for proper excitation-contraction coupling and cardiomyocyte function. These important parameters are usually adversely affected in cardiovascular diseases or under cardiotoxic conditions and can be measured using optical imaging-based techniques. However, this procedure is complex and technologically challenging. We have adapted the IonOptix system to simultaneously measure APs and Ca2+ transients in hiPSC-CMs loaded with the fluorescent dyes FluoVolt and Rhod 2, respectively. This system serves as a powerful high-throughput platform to facilitate the discovery of new compounds to treat cardiovascular diseases with the cellular phenotypes of abnormal APs and Ca2+ handling. Here, we present a comprehensive protocol for hiPSC-CM preparation, device setup, optical imaging, and data analysis. © 2024 Wiley Periodicals LLC. Basic Protocol 1: Maintenance and seeding of hiPSC-CMs Basic Protocol 2: Simultaneous detection of action potentials and Ca2+ transients in hiPSC-CMs.
Keywords: action potential; calcium transients; high‐throughput imaging; human induced pluripotent stem cell–derived cardiomyocytes; optical imaging.
© 2024 Wiley Periodicals LLC.
References
Literature Cited
-
- Blanch‐Asensio, A., Grandela, C., Brandão, K. O., de Korte, T., Mei, H., Ariyurek, Y., Yiangou, L., Mol, M. P. H., van Meer, B. J., Kloet, S. L., Mummery, C. L., & Davis, R. P. (2022). STRAIGHT‐IN enables high‐throughput targeting of large DNA payloads in human pluripotent stem cells. Cell Reports Methods, 2(10), 100300. https://doi.org/10.1016/j.crmeth.2022.100300
-
- Cheng, Y. S., Xu, M., Chen, G., Beers, J., Chen, C. Z., Liu, C., Zou, J., & Zheng, W. (2023). A protocol for culture and characterization of human induced pluripotent stem cells after induction. Current Protocols, 3(8), e866. https://doi.org/10.1002/cpz1.866
-
- Colatsky, T., Fermini, B., Gintant, G., Pierson, J. B., Sager, P., Sekino, Y., Strauss, D. G., & Stockbridge, N. (2016). The Comprehensive in vitro Proarrhythmia Assay (CiPA) initiative—Update on progress. Journal of Pharmacological and Toxicological Methods, 81, 15–20. https://doi.org/10.1016/j.vascn.2016.06.002
-
- Dempsey, G. T., Chaudhary, K. W., Atwater, N., Nguyen, C., Brown, B. S., McNeish, J. D., Cohen, A. E., & Kralj, J. M. (2016). Cardiotoxicity screening with simultaneous optogenetic pacing, voltage imaging and calcium imaging. Journal of Pharmacological and Toxicological Methods, 81, 240–250. https://doi.org/10.1016/j.vascn.2016.05.003
-
- Feyen, D. A. M., McKeithan, W. L., Bruyneel, A. A. N., Spiering, S., Hörmann, L., Ulmer, B., Zhang, H., Briganti, F., Schweizer, M., Hegyi, B., Liao, Z., Pölönen, R. P., Ginsburg, K. S., Lam, C. K., Serrano, R., Wahlquist, C., Kreymerman, A., Vu, M., Amatya, P. L., … Mercola, M. (2020). Metabolic maturation media improve physiological function of human iPSC‐derived cardiomyocytes. Cell Reports, 32(3), 107925. https://doi.org/10.1016/j.celrep.2020.107925
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous